Compound Detail
CHEMBL887
RASAGILINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL887 |
| Name | RASAGILINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | RUOKEQAAGRXIBM-GFCCVEGCSA-N |
| Therapeutic | ✓ Yes |
8
Targets
138
Activities
2
Assay Types
0
PK Parameters
20
Publications
5
Known Names
5
Indications
Molecular Properties
171.2
MW (Da)
1.90
ALogP
1
HBA
1
HBD
12.0
PSA (Ų)
0.67
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2005 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Parkinson Disease Supranuclear Palsy, Progressive Alzheimer Disease Amyotrophic Lateral Sclerosis Restless Legs Syndrome
ATC Classification
N04BD02
rasagiline
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS
Activity Summary
IC50 131 meas. best 9.0
Ki 7 meas. best 8.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Amine oxidase [flavin-containing] A CHEMBL3358 | IC50 | 9.0 | 7.04 | 1.0 | 4 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 8.85 | 8.85 | 1.4 | 1 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | IC50 | 8.4 | 7.3958 | 4.0 | 64 |
| Amine oxidase [flavin-containing] B CHEMBL2993 | IC50 | 8.37 | 7.2286 | 4.3 | 7 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | Ki | 8.12 | 6.89 | 7.6 | 5 |
| Acetylcholinesterase CHEMBL220 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Amine oxidase [flavin-containing] A CHEMBL1951 | IC50 | 7.5 | 5.7109 | 32.0 | 45 |
| Unchecked CHEMBL612545 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| Cholinesterase CHEMBL1914 | IC50 | 5.32 | 5.32 | 4760.0 | 1 |
| Amine oxidase [flavin-containing] A CHEMBL1951 | Ki | 5.01 | 5.01 | 9700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine